23andMe sold the stake/assets to TTAM Research Institute as part of a Bankruptcy Sale on not available.
Deal value was 305000000 (source: Extracted) Sector: Healthcare; Location: USA.
On the seller side, not available advised, led by Nicklas A. Akers, Bernard A. Eskandari, Stacey D. Schesser, Yen P. Nguyen, Daniel M.B. Nadal, Thomas H. Riske, Nathan R. Wallace, Jackson J. Gilkey, Paul M. Basta, Christopher Hopkins, William A. Clareman, Jeffrey J. Recher.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Paul, Weiss advises 23andMe on $305 million Chapter 11 asset sale of substantially all assets to TTAM Research Institute. | The Sponsor - The Sponsor
